Brain Tumours

Medulloblastoma: the (near) future

 Patients will be stratified for treatment on the basis of biological markers  Low risk: reduce therapy → reduce risks associated with treatment  High risk: intensify treatment/use novel treatment approaches  Possibility of developing agents that would target specific molecular aberrations